TTrialPathMatch Me to Trials
← Back to trials
RecruitingHeadacheHeadache DisordersHeadache, Migraine

Responding With Evidence and Access for Childhood Headaches

Eligible age

10–17 yrs

Accepts

All genders

Locations

14 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This comparative effectiveness study will clarify current first-line preventive treatment approaches for use by neurologists, psychologists, and primary care providers in the context of real world care, and will demonstrate the feasibility of Cognitive Behavioral Therapy (CBT) via telehealth for youth with migraine. The focus is on applying evidence-based care and enhancing access to it. CBT via telehealth while taking a clinically-prescribed, pill-based prevention therapy (amitriptyline) will be compared to CBT via telehealth alone.

Sponsor: Children's Hospital Medical Center, Cincinnati

You may qualify if…

  • Diagnosis: Migraine with or without aura that meets the International Classification of Headache Disorders (ICHD) criteria 5 or presentation of continuous headache that includes migranous episodes based upon headache history obtained by site PI or designee. (includes presentation with or without medication overuse headache as well)
  • Headache Frequency: 4 or more headache days based upon prospective headache diary of 28 days prior to randomization
  • Amitriptyline Eligible: Site PI or medical staff determined participant to be eligible for clinical prescription of amitriptyline as a preventive treatment for migraine
  • English fluency: Able to complete the study visits and questionnaires in English

You may not qualify if…

  • Current treatment includes amitriptyline and/or CBT specific to headache care
  • Current prescribed preventive antimigraine medication within a period equivalent to \< 5 half-lives of that medication before entering the baseline phase
  • Current treatment with onabotulinumtoxinA (Botox) or CGRP-based monoclonal antibody medications for migraine prevention
  • Youth who are pregnant
  • Report of current or ongoing suicidal thoughts. Suicide attempt within the past six months. History of bipolar disorder, prolonged QT, or pre-existing significant constipation or gastroparesis
  • Any and all other diagnoses or conditions which, in the opinion of the site investigator, would prevent the patient from being a suitable candidate for the study or interfere with the medical care needs of the participant

Where it's recruiting

Alabama

Birmingham

Arizona

Phoenix

California

San Francisco

Colorado

Aurora

Delaware

Wilmington

Georgia

Atlanta

Kentucky

Louisville

Louisiana

New Orleans

New York

Amherst

Ohio

Cincinnati · Columbus

Pennsylvania

Philadelphia

Tennessee

Memphis

Source: ClinicalTrials.gov · NCT05889624 · last updated 2026-03-06

Responding With Evidence and Access for Childhood Headaches · TrialPath